Determination of sequential mutation accumulation in pancreas and bile duct brushing cytology

Modern Pathology

Volumn 19, Issue 7, 2006, Pages 907-913

  Lapkus, Odeta ^a   Gologan, Olguta ^a   Liu, Yulin ^a   Swalsky, Patricia A ^b   Wilson, Matthew M ^b   Finkelstein, Sydney D ^b   Silverman, Jan F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Redpath Integrated Pathology Inc   (United States)

Author keywords

Cytology; Loss of heterozygosity; Mutation; Pancreaticobiliary brushing cytology; Temporal sequence of mutations

Indexed keywords

MOLECULAR MARKER;

ALLELIC IMBALANCE; ARTICLE; BILE DUCT; BILE DUCT TUMOR; CAPILLARY ELECTROPHORESIS; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 5Q; CYTOLOGY; FEASIBILITY STUDY; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MICRODISSECTION; MUTATION; PANCREAS; PANCREAS TUMOR; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BILIARY TRACT NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CYTODIAGNOSIS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENOTYPE; HUMANS; MICRODISSECTION; MUTATION; PANCREATIC NEOPLASMS; RAS PROTEINS; RETROSPECTIVE STUDIES;

EID: 33745203028     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800545     Document Type: Article

References (35)

1. Layfield LJ, Cramer H. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis. Diagn Cytopathol 2005;32:16-20.
2. Bartoletti R, Dal Canto M, Cai T, et al. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Oncol Rep 2005;13:531-537.
3. Acha A, Ruesga MT, Rodriguez MJ, et al. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal 2005;10:95-102.
4. Lal A, Bourtsos EP, DeFrias DV, et al. Microcystic adenoma of the pancreas: clinical, radiologic, and cytologic features. Cancer 2004;102:288-294.
5. Recine M, Kaw M, Evans DB, et al. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer 2004;102:92-99.
6. Basir Z, Pello N, Dayer AM, et al. Accuracy of cytologic interpretation of pancreatic neoplasms by fine needle aspiration and pancreatic duct brushings. Acta Cytol 2003;47:733-738.
7. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 2003;38:302-306.
8. Weiss RA. Multistage carcinogenesis. Br J Cancer 2004;91:1981-1982.
9. Owens DM, Wei S, Smart RC. A multihit, multistage model of chemical carcinogenesis. Carcinogenesis 1999;20:1837-1844.
10. Mohan D, Finkelstein SD, Swalsky PA, et al. Microdissection genotyping of gliomas: therapeutic and prognostic considerations. Mod Pathol 2004;17:1346-1358.
11. McLendon R, Swalsky P, Finkelstein S. Determination and significance of the timing of 1p/19q allelic loss in relation to aggressive mutations (9p, 10q, 17p) in gliomas. J Neuropathol Exp Neurol 2004;63:551.
12. Chow M, Rubin H. Clonal dynamics of progressive neoplastic transformation. Proc Natl Acad Sci USA 1999;96:6976-6981.
13. Losi L, Baisse B, Bouzourene H, et al. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 2005;26:916-922.
14. Breivik J. The evolutionary origin of genetic instability in cancer development. Semin Cancer Biol 2005;15:51-60.
15. Cahill DP, Kinzler KW, Vogelstein B, et al. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999;9:M57-M60.
16. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649.
17. Finkelstein SD, Marsh W, Demetris AJ, et al. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology 2003;37:871-879.
18. Ohori NP, Khalid A, Etemad B, et al. Multiple loss of heterozygosity without K-ras mutation identified by molecular analysis on fine-needle aspiration cytology specimen of acinar cell carcinoma of pancreas. Diagn Cytopathol 2002;27:42-46.
19. Khalid A, Pal R, Sasatomi E, et al. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 2004;53:1860-1865.
20. Luttges J, Kloppel G. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities. Dig Dis 2001;19:15-23.
21. Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am J Surg Pathol 2003;186:279-286.
22. Yeo TP, Hruban RH, Leach SD, et al. Pancreatic cancer. Curr Probl Cancer 2002;26:176-275.
23. Hunt JL, Finkelstein SD. Microdissection techniques for molecular testing in surgical pathology. Arch Pathol Lab Med 2004;128:1372-1378.
24. Hardiman G. Microarray platforms-comparisons and contrasts. Pharmacogenomics 2004;5:487-502.
25. Rickert CH, Paulus W. Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence. J Neuropathol Exp Neurol 2004;63:399-417.
26. Wulfkuhle J, Espina V, Liotta L, et al. Genomic and proteomic technologies for individualisation and improvement of cancer treatment. Eur J Cancer 2004;40:2623-2632.
27. Sasatomi E, Finkelstein SD, Woods JD, et al. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res 2002;62:2681-2689.
28. Khalid A, McGrath K, Zahid M, et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005;3:967-973.
29. Basir Z, Pello N, Dayer AM, et al. Accuracy of cytologic interpretation of pancreatic neoplasms by fine needle aspiration and pancreatic duct brushings. Acta Cytol 2003;47:733-738.
30. Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc 2003;58:701-706.
31. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-799.
32. Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 2000;190:412-416.
33. Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci 2004;95:197-204.
34. Ingvarsson S. Genetics of breast cancer. Drugs Today (Barcelona) 2004;40:991-1002.
35. Pan H, Califano J, Ponte JF, et al. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer. Cancer Res 2005;65:1664-1669.